Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by mollevi
Group name EquipeLLC
Item Type Note
Note The following values have no corresponding Zotero field:
auth-address: Institut National de la Sante et de la Recherche Medicale (INSERM), Cancer Research Center of Toulouse, U1037, F-31024 Toulouse, France Universite de Toulouse, F-31300 Toulouse, France Service d'Hematologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer Toulouse Oncopole, F-31059 Toulouse, France. Institut National de la Sante et de la Recherche Medicale (INSERM), Cancer Research Center of Toulouse, U1037, F-31024 Toulouse, France Universite de Toulouse, F-31300 Toulouse, France. Universite de Toulouse III Paul Sabatier, Institut National des Sciences Appliquees, UPS, Institut National Polytechnique, L'Ingenierie des Systemes Biologiques et des Procedes, F-31077 Toulouse, France Institut National de la Recherche Agronomique (INRA), UMR792, Ingenierie des Systemes Biologiques et des Procedes, F-31400 Toulouse, France Centre National de la Recherche Scientifique, UMR5504, F-31400 Toulouse, France. CEA/DSV/iBiTec-S/SPI, Laboratoire d'Etude du Metabolisme des Medicaments, MetaboHUB-Paris, F-91191 Gif-sur-Yvette, France. Genomics Research Unit, Centre de Recherche Public de la Sante, 1526 Luxembourg City, Luxembourg. INSERM, U1194, Institut de Recherche en Cancerologie de Montpellier, F-34298 Montpellier, France Universite de Montpellier, F-34298 Montpellier, France Institut regional du Cancer Montpellier, F-34298 Montpellier, France. Organic Synthesis Core Facility, Memorial Sloan-Kettering Cancer Center, New York, NY 10065. Sorbonne Universites, Universite Pierre-et-Marie-Curie (UPMC) Paris VI, UMR-S 938, CDR Saint-Antoine, F-75012 Paris, France INSERM, UMR-S938, CDR Saint-Antoine, F-75012 Paris, France Sorbonne Universites, UPMC Paris VI, GRC n degrees 07, Groupe de Recherche Clinique sur les Myeloproliferations Aigues et Chroniques MyPAC, F-75012 Paris, France AP-HP, Hopital Saint-Antoine, F-75012 Paris, France. INRA, UMR1331, Toxalim, Research Centre in Food Toxicology, F-31027 Toulouse, France Universite de Toulouse, INP, Toxalim, UMR1331, F-31027 Toulouse, France. Institut National de la Sante et de la Recherche Medicale (INSERM), Cancer Research Center of Toulouse, U1037, F-31024 Toulouse, France Universite de Toulouse, F-31300 Toulouse, France jean-emmanuel.sarry@inserm.fr.
alt-title: The Journal of experimental medicine
number: 4
accession-num: 26951332
Tags _EndnoteXML import
Date Added 2018/11/14 - 11:59:48
Date Modified 2018/11/14 - 11:59:48
Parent item Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés